Cargando…

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes

β-Cell function improves in patients with type 2 diabetes in response to an oral glucose stimulus after Roux-en-Y gastric bypass (RYGB) surgery. This has been linked to the exaggerated secretion of glucagon-like peptide 1 (GLP-1), but causality has not been established. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jørgensen, Nils B., Dirksen, Carsten, Bojsen-Møller, Kirstine N., Jacobsen, Siv H., Worm, Dorte, Hansen, Dorte L., Kristiansen, Viggo B., Naver, Lars, Madsbad, Sten, Holst, Jens J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749359/ https://www.ncbi.nlm.nih.gov/pubmed/23649520 http://dx.doi.org/10.2337/db13-0022

Ejemplares similares

Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2019)

Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion: A case report
por: Dirksen, Carsten, et al.
Publicado: (2010)

Chenodeoxycholic acid stimulates glucagon‐like peptide‐1 secretion in patients after Roux‐en‐Y gastric bypass
por: Nielsen, Signe, et al.
Publicado: (2017)

Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
por: Hedbäck, Nora, et al.
Publicado: (2022)

Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Jonsson, Isabella, et al.
Publicado: (2021)

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake
por: Bojsen-Møller, Kirstine Nyvold, et al.
Publicado: (2023)

Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2
por: Fenger, Mogens, et al.
Publicado: (2016)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota
por: Palleja, Albert, et al.
Publicado: (2016)

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss()
por: Holst, Jens Juul, et al.
Publicado: (2018)

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery
por: Li, Qing-Run, et al.
Publicado: (2018)

Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery—An observational cohort study of changes in urinary markers
por: Carlsson, Elin Rebecka, et al.
Publicado: (2020)

Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine
por: Modvig, Ida M., et al.
Publicado: (2020)

Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies
por: Pedersen, Julie Steen, et al.
Publicado: (2021)

Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes
por: Lindegaard, Kirsten Katrine, et al.
Publicado: (2015)

Effects of Roux-en-Y Gastric Bypass on Fasting and Postprandial Levels of the Inflammatory Markers YKL-40 and MCP-1 in Patients with Type 2 Diabetes and Glucose Tolerant Subjects
por: Thomsen, Stine Brinkløv, et al.
Publicado: (2013)

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2017)

Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
por: Carlsson, Elin Rebecka, et al.
Publicado: (2018)

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass
por: Tharakan, George, et al.
Publicado: (2017)

Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study
por: Carlsson, Elin Rebecka, et al.
Publicado: (2019)

Fractionated free fatty acids and their relation to diabetes status after Roux‐en‐Y gastric bypass: A cohort study
por: Eriksen, Freja, et al.
Publicado: (2021)

Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
por: Madsbad, Sten
Publicado: (2015)

Genetic markers of abdominal obesity and weight loss after gastric bypass surgery
por: Aasbrenn, Martin, et al.
Publicado: (2021)

Roux-en-Y Gastric Bypass Increases Glycemic Excursions During Pregnancy and Postpartum: A Prospective Cohort Study
por: Stentebjerg, Louise L., et al.
Publicado: (2023)

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2022)

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report
por: Knop, Filip K, et al.
Publicado: (2014)

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Shah, Meera, et al.
Publicado: (2014)

Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men
por: Asmar, Ali, et al.
Publicado: (2017)

The prevalence of comorbidities in Danish patients with obesity – A Danish register‐based study based on data from 2002 to 2018
por: Pedersen, Mikkel H., et al.
Publicado: (2022)

Exaggeration
por: Chandler, J. B.
Publicado: (1880)

Robotic Roux-en-Y Gastric Bypass Procedure Guide
por: Kersebaum, Jan-Niclas, et al.
Publicado: (2020)

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study
por: Kumarathurai, Preman, et al.
Publicado: (2016)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures
por: Lundgren, Julie R., et al.
Publicado: (2019)

Management of suspected anastomotic leak after bariatric laparoscopic Roux-en-y gastric bypass
por: Jacobsen, H J, et al.
Publicado: (2014)

PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery
por: Ramracheya, Reshma D., et al.
Publicado: (2016)

Eating in mice with gastric bypass surgery causes exaggerated activation of brainstem anorexia circuit
por: Mumphrey, Michael B., et al.
Publicado: (2016)

What is Diabetes Remission?
por: Holst, Jens J., et al.
Publicado: (2021)

Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity
por: O’Keefe, Stephen J D, et al.
Publicado: (2017)

Laparoscopic Roux-en-“W” Gastric Bypass
por: Rovito, Peter E.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_39nofgi4vdgmn6egsnfo3l5ise